Boards @MIT @VoyagerTx @BloomScience Emm; former CEO InCarda; alum @MITChemE @Penn; #PuertoRican #BLM #LatinX🇵🇷🌈🌊 follow @gracecolon on 🦋; opinions my own
Los Gatos, CA
Joined November 2015
- Tweets3.4K
- Following7.6K
- Followers7.8K
- Likes14.4K
Grace E. Colón, Ph.D. (she/her/they) retweeted
The 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E. Colón. trib.al/T1bTlOw
Grace E. Colón, Ph.D. (she/her/they) retweeted
On today’s #BiotechHangout @ColonGraceE, @TimOpler, @soowannaway (Graig Suvannavejh), & @EricSchmidt151 will cover market sentiment: 2026 biopharma market outlook, a bull/bear debate on the sector, companies gearing up for IPOs – are we ready?, deals: $GSK’s $2.2B acquisition of $RAPT, $JANX / $BMY $850M deal, policy: US exits the WHO, latest biotech funding bill topics, FDA’s MRD-negative guidelines for myeloma, company news: $CRVS Ph1 atopic dermatitis data (stock jump & competitive landscape), plus @TimOpler’s women’s health report & much more: xitter.cf/i/spaces/1PlJQOp…
Grace E. Colón, Ph.D. (she/her/they) retweeted
On today's #BiotechHangout, @ColonGraceE, @cngarabedian, @SamFazeli8, @MatteisPaul, @YaronWerber, and special guest @johnbstanford will cover policy: NDAA provisions & implications for biotech, industry trends & deals: big Monday w/ $1.85B in biotech financings – most in one day?, $XBI’s sustained momentum & positive signals, $LLY’s acquisitive strategy, plus Fosun+$PFE deal for oral GLP-1, conferences: #ASH2025 ($AZN, $LLY vs $ONC, $JNJ/$LEGN vs $GILD/ACLX, $GMAB, $TERN), #ESMOAsia25 ($BNTX, Zelgen, $GSK, & other ADCs), $CGON at #SUO25, plus other data: $DYN positive DMD data, obesity news ($GPCR, $WVE, Ascletis), Endpoints 100 takeaways & much more: xitter.cf/i/spaces/1lPKqvd…
Grace E. Colón, Ph.D. (she/her/they) retweeted
Interesting. Journals publishing NIH funded research now need to do so as #openaccess cc @phylogenomics
🚨 New NIH Public Access Policy goes into effect TODAY! Research accepted for publication on July 1, 2025, must be publicly available as soon as it is published. This date was moved up from December 31, 2025, to ensure radical transparency regarding the research NIH supports.
Read more from @NIHDirector_Jay ➡️ go.nih.gov/zQRDiuk
ALT Now in Effect: NIH Public Access Policy Starting July 1, 2025, all NIH-funded research must be publicly available when published.
Grace E. Colón, Ph.D. (she/her/they) retweeted
On today’s #BiotechHangout, @SamFazeli8, @JMaraganore, @nkjellson, and @gline discuss MFN (Most Favored Nation): the 30-day pharma ultimatum, 180 days for negotiation, reimportation – is this possible?, ex-US prices, DTC sales, Roche’s threats to pull back US investments, $SNY joins ‘invest in US’ list w/$20B to 2030 pledge, & in other news: budget reconciliation proposals -Orphan Cures, PBM reform & R&D tax reduction, IRA Part B guidance ($HALO hit hard), $RXRX trims pipeline & InSilico HK’s 3rd IPO attempt – a reckoning for AI drug discovery?, the Galapagos rollercoaster, $CTMX back from the dead, $GSK buys Boston Ph3-ready liver drug, $GSK/iTeos TIGIT update, $NVO CEO fired, RNA deals: $LLY/Rznomics $1B deal & $ABBV/ADARx $335M upfront cash, & much more: xitter.cf/i/spaces/1OwGWXA…
Grace E. Colón, Ph.D. (she/her/they) retweeted
Importing socialized medicine won’t make Americans healthier. It will empower China and our adversaries, risk patient access, and cost American jobs.
Grace E. Colón, Ph.D. (she/her/they) retweeted
On today’s #BiotechHangout, @ColonGraceE, @biotech1 (Josh Schimmer), @SamFazeli8, @t_lorriman, @ericschmidt151, @YaronWerber discuss new CBER director Vinay Prasad, Trump’s surgeon general pick Casey Means, $SRPT’s news, Medicaid MFN, tariff updates, $NVAX COVID vaccine update, $GSK’s missed PDUFA, data: Genocury’s first in vivo CAR-T, $PTC’s #HuntingtonsDisease update, a choppy Q1 & earnings: $KRYS, $NVO, $RVMD, $BNTX, & much more: xitter.cf/i/spaces/1zqJVjb…
Grace E. Colón, Ph.D. (she/her/they) retweeted
On one side, nothing but hate, division, and anger. On the other, happiness, optimism, and hope. You know which side to choose.
Grace E. Colón, Ph.D. (she/her/they) retweeted
Check out the full list of signatories, and sign the pledge, on vcsforkamala.org
And join us 💪
#vcsforkamala #vcsfordemocracy
Grace E. Colón, Ph.D. (she/her/they) retweeted
I’m Kamala Harris, and I’m running for President of the United States.
Grace E. Colón, Ph.D. (she/her/they) retweeted
It's just not right... why does insurance charge people out-of-pocket for a medicine no one would take if they didn't have to?
We need to cap these costs for patients and #fixinsurance.
Please share and help, @MariahCarey , @jessicaalba, @Eminem, @Pink, @JeromeBettis36!
Grace E. Colón, Ph.D. (she/her/they) retweeted
Frankly, women deserve more from our industry. They deserve investors speaking up and declaring women’s health as a critical area for healthcare investment and putting their dollars to work to help us accelerate the innovation to market @SabrinaDareCEO
fiercebiotech.com/biotech/or…
Grace E. Colón, Ph.D. (she/her/they) retweeted
We're at a point in history where we can't pull any punches. We do really need to be very blunt about what we're talking about. There's a long lack of equality at all levels, and we focused on that, now that we have positions of leadership
-Grace Colon CEO
fiercebiotech.com/biotech/or…
Grace E. Colón, Ph.D. (she/her/they) retweeted
On today’s #BiotecHangout @daphnezohar @bradloncar @LifeSciVC @biotech1 @EricSchmidt151 @SamFazeli8 @ColonGraceE will discuss the 2024 class of IPOs, “everything is awesome” CEOs, managing your board, dealing with a stock drop ($CABA, $KYTX, $TSHA, $OVID, $AVTE), $MIRM’s positive update, BioNTech’s clinical hold, #EHA2024 highlights ($GRCL’s GC012F remarkable efficacy), general market overview and more: xitter.cf/i/spaces/1zqKVqq…
Grace E. Colón, Ph.D. (she/her/they) retweeted
Today on #BiotechHangout, @cngarabedian @bradloncar @biotech1 @ericschmidt151 @timopler cover $INCY’s $2B share repurchase, stock buybacks & ‘broken’ R&D model, deals: Blackstone/Uniquity launch ($300M), $JNJ buys Proteologix ($850M) & recent deals on China assets to US, data: Bayer's Ph3 readouts for menopause, $MRK TIGIT/PD-1 Ph3 safety concerns, $IONS/$BIIB discontinue ALS treatment, obesity ‘limited data’ vs $VKTX data transparency, $SGIOY & $AZN COVID-19 data, plus #ASGCT2024 recap, $BOLT discontinues oncology asset, $DVAX denied expanded use by FDA, $RXRX’s stock surge, short selling & meme stocks ($NVAX) & more: xitter.cf/i/spaces/1MYGNok…
Grace E. Colón, Ph.D. (she/her/they) retweeted
Here's William Jones who authored the 1864 Arizona abortion bill.
Some fun facts:
He abandoned his first wife and their children in Missouri.
His second wife was a 12 year old Mexican girl. He abducted her and after a complaint submitted his resignation to President Buchanan before he was fired.
In 1864 (age 49) he married his 3rd wife, a 15 year old girl he abandoned in 1865 when he moved to Hawaii.
This is the guy who wrote the law that millions of Arizona women will be forced to obey.
His life is a series of grifts, and he was known for being a "pursuer of nubile females".
en.m.wikipedia.org/wiki/W._C…
Grace E. Colón, Ph.D. (she/her/they) retweeted
On today’s #BiotechHangout, @bradloncar @biotech1 @cngarabedian @ColonGraceE @EricSchmidt151 discuss data from $RHHBY’s Ph3 Enspryng gMG trial & $CRNX Ph3 Paltusotine trial, $AZN acq of $FUSN & the radiopharm space, Mirador launch (former Prometheus team) & megarounds, rare disease news: newly approved Lenmedly’s $4.25M price tag, creation of Orphan Therapeutics Accelerator, & lobbying exceptions for orphan drugs, plus this week’s executive order on women’s health research, BIO’s position reversal on BioSecure Act, and more: xitter.cf/i/spaces/1OyJAWA…
Grace E. Colón, Ph.D. (she/her/they) retweeted
Cells are fast and crowded places. Numbers help us make sense of them.
Here are five of my favorite "bionumbers."
1. ATP synthase spins 134 times/second. That is much faster than the propeller on most piston airplanes, and about half the r.p.m. of a Boeing 737 jet engine.
Grace E. Colón, Ph.D. (she/her/they) retweeted
Today on #BiotechHangout @daphnezohar @TimOpler @eperlste @TheDawnBell @EricSchmidt151 discuss $GILD acquiring $CBAYfor $4.3B, tracking 13F filings, quiet week on the IPO front & what $MGX reception means for IPO window, Ipsen FDA approval triggers $225M milestone payment to $MACK, plus data: $KALV Ph3 hits endpoints & CSL’s Ph3 trial ends, $ALY’s changes to its HELIOIS-B Ph3 study of vutrisiran, $LIAN shutting down & the continued sanctions against China biotechs, plus offerings: $LRMR, $SANA, $CRSP, $PRME, private financings: BioAge Labs $170M Series D & Latigo’s $135M Series A, & more: xitter.cf/i/spaces/1kvKpvZ…
